Extended DaraKRd: Are we enhancing outcomes by prolonging treatment?
TM Schmidt - Blood Cancer Journal, 2024 - nature.com
In the manuscript that accompanies this editorial, Derman, et al. report the final analysis of a
phase 2 clinical trial of extended daratumumab, carfilzomib, lenalidomide, and …
phase 2 clinical trial of extended daratumumab, carfilzomib, lenalidomide, and …